LITS
Lite Strategy, Inc.Company Information
- Company Name
- Lite Strategy, Inc.
- CIK
- CIK0001262104
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- LITS: Nasdaq
- Fiscal Year End
- June 30
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- LITS
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-06-24
- Last sale
- 2025-12-18
- Shares purchased (TTM)
- 107,100
- Shares sold (TTM)
- 690,611
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 5,824,499
- Shares outstanding
- 35,711,000
- Ownership
- 16.31%
Earnings Market Reaction
- Filing date
- 2026-09-28
- Price on filing date
- —
- 1-month reaction
- Pending
- 3-month reaction
- Pending
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 6 | 8 | 9 | 10 | 18 | 20 | 24 | 7 | 4 | 2 | 5 | 3 | ||||||
| Short Term Investments | - | - | - | - | 0 | 0 | 0 | 20 | 35 | 54 | 54 | 79 | ||||||
| Unbilled Receivables Current | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | ||||||
| Crypto Asset Fair Value Current | - | 2 | - | - | - | - | - | - | - | - | - | - | ||||||
| Prepaid Expense And Other Assets Current | 0 | 1 | 2 | 3 | 0 | 0 | 1 | 1 | 2 | 3 | 7 | 6 | ||||||
| Assets Current | 6 | 11 | 11 | 13 | 18 | 21 | 24 | 28 | 41 | 59 | 66 | 88 | ||||||
| Operating Lease Right Of Use Asset | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 11 | 11 | 12 | ||||||
| Property Plant And Equipment Net | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | ||||||
| Crypto Asset Fair Value | - | 40 | 64 | 99 | - | - | - | - | - | - | - | - | ||||||
| Crypto Asset Fair Value Noncurrent | - | 38 | - | - | - | - | - | - | - | - | - | - | ||||||
| Other Assets Noncurrent | - | 1 | 1 | 1 | - | - | - | - | - | - | - | - | ||||||
| Assets | 43 | 58 | 83 | 113 | 18 | 21 | 24 | 28 | 41 | 71 | 79 | 101 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 3 | 3 | 1 | 3 | ||||||
| Accrued Liabilities Current | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 5 | 5 | 6 | 4 | ||||||
| Liabilities Current | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 8 | 10 | 8 | 9 | ||||||
| Deferred Revenue Current | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 8 | 20 | 19 | 20 | ||||||
| Operating Lease Liability Current | - | - | - | - | - | - | - | - | 0 | 1 | 1 | 1 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Deferred Revenue Noncurrent | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability Noncurrent | - | - | - | - | - | - | - | - | 0 | 11 | 11 | 11 | ||||||
| Additional Paid In Capital Common Stock | 522 | 521 | 521 | 520 | 421 | 421 | 421 | 421 | 421 | 421 | 420 | 431 | ||||||
| Treasury Stock Common Value | - | -2 | -0 | - | - | - | - | - | - | - | - | - | ||||||
| Retained Earnings Accumulated Deficit | -475 | -462 | -439 | -408 | -404 | -401 | -399 | -396 | -388 | -370 | -361 | -350 | ||||||
| Stockholders Equity | 42 | 57 | 82 | 112 | 17 | 20 | 22 | 25 | 33 | 51 | 59 | 81 | ||||||
| Liabilities And Stockholders Equity | 43 | 58 | 83 | 113 | 18 | 21 | 24 | 28 | 41 | 71 | 79 | 101 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 226 | 226 | 226 | 226 | 226 | 226 | 226 | 226 | 226 | 226 | 226 | 226 | ||||||
| Common Stock Shares Issued | 37 | 37 | 37 | 36 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | ||||||
| Shares Outstanding | 32 | 35 | - | 36 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | ||||||
| Treasury Stock Common Shares | - | 2 | 0 | - | - | - | - | - | - | - | - | - | ||||||
Select a line item above to chart it.
Recent filings
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialLite Strategy, Inc. (LITS) — SEC Financial Statements & Analysis
Lite Strategy, Inc. (LITS) is a pharmaceutical preparations company, incorporated in DE. Lite Strategy, Inc. trades on Nasdaq as: LITS. Lite Strategy, Inc. (LITS)'s most recent SEC filing is a Form 10-K for the period ended 2026-06-30, filed with the SEC on 2026-09-28. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Lite Strategy, Inc. carries a market cap of $31.79M, a P/E ratio of -0.45x, a P/B ratio of 0.76x, a P/S ratio of 0.30x, an enterprise value of $26.09M, and an EV/EBITDA multiple of -0.39x. On profitability, it posts an operating margin of 22.27%, a net margin of 27.23%, a Return on Equity (ROE) of -243.02%, a Return on Assets (ROA) of -233.37%, and a Return on Invested Capital (ROIC) of -382.22%. Per share, it reports EPS of $-2.06, diluted EPS of $-2.06, free cash flow per share of $-0.26, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of 346.22% year-over-year, and EPS growth of -13.97% year-over-year. On the balance sheet, it maintains a current ratio of 5.74x, a quick ratio of 5.34x, working capital of $5.07M, a debt-to-equity ratio of 0.03x, a debt ratio of 0.03, free cash flow of $-9.12M (TTM), and net debt of $-5.71M. Figures sourced from SEC EDGAR.
- Market Cap
- $31.79M
- P/E TTM
- -0.45x
- EPS TTM
- $-2.06
- P/B TTM
- 0.76x
- ROE TTM
- -243.02%
- ROA TTM
- -233.37%
- Debt To Equity
- 0.03x
- Free Cash Flow TTM
- $-9.12M
- Net Revenue TTM Growth 1Y
- -100.00%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Lite Strategy, Inc. in?
Lite Strategy, Inc. (LITS) operates in the Pharmaceutical Preparations industry.
What exchange does LITS trade on?
Lite Strategy, Inc. (LITS) trades on the Nasdaq.
Where is Lite Strategy, Inc. incorporated?
Lite Strategy, Inc. is incorporated in DE.
When was Lite Strategy, Inc. (LITS)'s most recent SEC filing?
Lite Strategy, Inc. (LITS)'s most recent SEC filing is a Form 10-K for the period ended 2026-06-30, filed with the SEC on 2026-09-28.
What is LITS's market cap?
Lite Strategy, Inc. (LITS) has a market capitalization of $31.79M as of 2026-06-30.
What is LITS's EPS (earnings per share)?
Lite Strategy, Inc. (LITS)'s trailing twelve month EPS is $-2.06 as of 2026-06-30.
What is LITS's ROE (return on equity)?
Lite Strategy, Inc. (LITS)'s trailing twelve month Return on Equity (ROE) is -243.02% as of 2026-06-30.
What is LITS's ROA (return on assets)?
Lite Strategy, Inc. (LITS)'s trailing twelve month Return on Assets (ROA) is -233.37% as of 2026-06-30.
What is LITS's ROIC (return on invested capital)?
Lite Strategy, Inc. (LITS)'s trailing twelve month Return on Invested Capital (ROIC) is -382.22% as of 2026-06-30.
What is LITS's EV/EBITDA?
Lite Strategy, Inc. (LITS)'s trailing twelve month EV/EBITDA is -0.39x as of 2026-06-30.